Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: A&G PHARMACEUTICAL, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-09-24 to 2026-09-23
Current total value of award: $13600
Description: TO GENERATE REAGENTS AGAINST AZM-152, A DRUG CANDIDATE FROM TDB AZOME PROJECT.